FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975768263> ?p ?o ?g. }

• W1975768263 endingPage "504" @default.
• W1975768263 startingPage "497" @default.
• W1975768263 abstract "To determine whether angiotensin-converting enzyme (ACE) inhibition with captopril reduces the progression of microalbuminuria to overt proteinuria in normotensive patients with insulin-dependent diabetes mellitus (IDDM).This study was a prospective randomized, double-blind, placebo-controlled trial involving 26 centers in the United States and Canada. One hundred forty-three subjects, 14 to 57 years of age, with IDDM for 4 to 33 years, blood pressure < 140/90 mm Hg in the absence of antihypertensive therapy, and persistent albumin excretion 20 to 200 micrograms/min were randomized to double-blind treatment with captopril 50 mg or placebo BID. Albumin excretion rate (AER), blood pressure, and glycohemoglobin were determined every 3 months, and creatinine clearance (CrCl) and urea excretion were measured every 6 months.Within 24 months, 6.0% (4/67) of captopril-treated subjects and 18.6% (13/70) of placebo-treated subjects progressed to clinical proteinuria, defined as AER > 200 micrograms/min and at least 30% above baseline (risk reduction = 67.8%, P = 0.037). AER increased at an annual rate of 11.8% (95% confidence interval [CI] -3.3% to 29.1%) in the placebo group, while it declined by 17.9% (CI -29.6% to -4.3%) in the captopril group (P = 0.004). CrCl decreased by 4.9 mL/min per 1.73 m2 per year in the placebo group, while it remained stable in the captopril group (0.9 mL/min per 1.73 m2 per year, P = 0.039 between groups). Ten subjects required treatment for hypertension; 8 in the placebo group and 2 in the captopril group. There was little correlation between the 24-month changes in mean arterial blood pressure and AER in either group. Glycohemoglobin and urinary urea excretion did not differ between groups.After 24 months of therapy with captopril, compared with placebo, normotensive subjects with IDDM experienced significantly less progression of microalbuminuria to clinical proteinuria, reduced albumin excretion, and preserved CrCl rate. The ACE inhibitor, captopril, was well tolerated." @default.
• W1975768263 created "2016-06-24" @default.
• W1975768263 creator A5024239148 @default.
• W1975768263 creator A5050076657 @default.
• W1975768263 creator A5069785394 @default.
• W1975768263 date "1995-11-01" @default.
• W1975768263 modified "2023-10-12" @default.
• W1975768263 title "The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria" @default.
• W1975768263 cites W1968206542 @default.
• W1975768263 cites W1982964431 @default.
• W1975768263 cites W1995937915 @default.
• W1975768263 cites W1996485736 @default.
• W1975768263 cites W2001049748 @default.
• W1975768263 cites W2004043215 @default.
• W1975768263 cites W2010025671 @default.
• W1975768263 cites W2013987899 @default.
• W1975768263 cites W2021722695 @default.
• W1975768263 cites W2022230104 @default.
• W1975768263 cites W2025439636 @default.
• W1975768263 cites W2026253019 @default.
• W1975768263 cites W2033503356 @default.
• W1975768263 cites W2043623132 @default.
• W1975768263 cites W2044276013 @default.
• W1975768263 cites W2046303127 @default.
• W1975768263 cites W2048414885 @default.
• W1975768263 cites W2050424521 @default.
• W1975768263 cites W2053248115 @default.
• W1975768263 cites W2061033381 @default.
• W1975768263 cites W2073935745 @default.
• W1975768263 cites W2088865109 @default.
• W1975768263 cites W2091793468 @default.
• W1975768263 cites W2096810815 @default.
• W1975768263 cites W2106915854 @default.
• W1975768263 cites W2136898798 @default.
• W1975768263 cites W2141230518 @default.
• W1975768263 cites W2322256252 @default.
• W1975768263 cites W2322552681 @default.
• W1975768263 cites W2326032252 @default.
• W1975768263 cites W2332239235 @default.
• W1975768263 cites W2338357348 @default.
• W1975768263 cites W2340025308 @default.
• W1975768263 cites W2615684303 @default.
• W1975768263 cites W2769264260 @default.
• W1975768263 cites W4293241248 @default.
• W1975768263 cites W4323238053 @default.
• W1975768263 doi "https://doi.org/10.1016/s0002-9343(99)80226-5" @default.
• W1975768263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7485207" @default.
• W1975768263 hasPublicationYear "1995" @default.
• W1975768263 type Work @default.
• W1975768263 sameAs 1975768263 @default.
• W1975768263 citedByCount "264" @default.
• W1975768263 countsByYear W19757682632012 @default.
• W1975768263 countsByYear W19757682632013 @default.
• W1975768263 countsByYear W19757682632014 @default.
• W1975768263 countsByYear W19757682632015 @default.
• W1975768263 countsByYear W19757682632016 @default.
• W1975768263 countsByYear W19757682632017 @default.
• W1975768263 countsByYear W19757682632018 @default.
• W1975768263 countsByYear W19757682632019 @default.
• W1975768263 countsByYear W19757682632020 @default.
• W1975768263 countsByYear W19757682632021 @default.
• W1975768263 countsByYear W19757682632022 @default.
• W1975768263 crossrefType "journal-article" @default.
• W1975768263 hasAuthorship W1975768263A5024239148 @default.
• W1975768263 hasAuthorship W1975768263A5050076657 @default.
• W1975768263 hasAuthorship W1975768263A5069785394 @default.
• W1975768263 hasConcept C10146269 @default.
• W1975768263 hasConcept C126322002 @default.
• W1975768263 hasConcept C126894567 @default.
• W1975768263 hasConcept C134018914 @default.
• W1975768263 hasConcept C142724271 @default.
• W1975768263 hasConcept C159641895 @default.
• W1975768263 hasConcept C204787440 @default.
• W1975768263 hasConcept C27016395 @default.
• W1975768263 hasConcept C27081682 @default.
• W1975768263 hasConcept C2779479957 @default.
• W1975768263 hasConcept C2779561371 @default.
• W1975768263 hasConcept C2779611605 @default.
• W1975768263 hasConcept C2779922275 @default.
• W1975768263 hasConcept C2780091579 @default.
• W1975768263 hasConcept C2781184683 @default.
• W1975768263 hasConcept C2781203188 @default.
• W1975768263 hasConcept C555293320 @default.
• W1975768263 hasConcept C71924100 @default.
• W1975768263 hasConcept C84393581 @default.
• W1975768263 hasConcept C90924648 @default.
• W1975768263 hasConceptScore W1975768263C10146269 @default.
• W1975768263 hasConceptScore W1975768263C126322002 @default.
• W1975768263 hasConceptScore W1975768263C126894567 @default.
• W1975768263 hasConceptScore W1975768263C134018914 @default.
• W1975768263 hasConceptScore W1975768263C142724271 @default.
• W1975768263 hasConceptScore W1975768263C159641895 @default.
• W1975768263 hasConceptScore W1975768263C204787440 @default.
• W1975768263 hasConceptScore W1975768263C27016395 @default.
• W1975768263 hasConceptScore W1975768263C27081682 @default.
• W1975768263 hasConceptScore W1975768263C2779479957 @default.
• W1975768263 hasConceptScore W1975768263C2779561371 @default.
• W1975768263 hasConceptScore W1975768263C2779611605 @default.

• next